PP
VIVO

Paloma Partners’s Meridian Bioscience Inc VIVO Stock Holding History

Paloma Partners’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,037
Closed -$209K – 1937
2022
Q1 		$209K Buy
+8,037
New +$191K 0.01% 1375
2021
Q2 		– Sell
-15,592
Closed -$409K – 2447
2021
Q1 		$409K Buy
+15,592
New +$371K 0.01% 1275
2020
Q3 		– Sell
-10,722
Closed -$250K – 2606
2020
Q2 		$250K Buy
+10,722
New +$155K ﹤0.01% 1572
2019
Q3 		– Sell
-44,702
Closed -$531K – 2382
2019
Q2 		$531K Buy
+44,702
New +$539K 0.01% 999
2014
Q1 		– Sell
-7,785
Closed -$207K – 1074
2013
Q4 		$207K Buy
+7,785
New +$191K 0.01% 912

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Paloma Partners's VIVO Position: Q2 2022 in Review

Paloma Partners sold out of Meridian Bioscience Inc (VIVO) in Q2 2022, closing a stake of 8,037 shares — an estimated $209K sold.

Paloma Partners first reported a position in VIVO in Q4 2013 and held it in 5 quarters. The position peaked at $531K in Q2 2019. 216 funds tracked by Wall St. Rank hold VIVO as of Q2 2022.

  • Paloma Partners reported no remaining Meridian Bioscience Inc position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 8,037 Meridian Bioscience Inc shares in Q2 2022, an estimated $209K.
  • Paloma Partners first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 5 quarters.
  • Paloma Partners's Meridian Bioscience Inc position peaked at $531K in Q2 2019.
  • 216 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.